China on Friday retaliated against U.S. President Donald Trump’s reciprocal tariffs by raising its levies on U.S. goods to 125% from 84%, the Chinese finance ministry said. “Even if the U.S. continu… [+3365 chars]Read More
Eli Lillys nextgeneration obesity drug retatrutide clears first latestage diabetes trial CNBC
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
